Quarterly report pursuant to Section 13 or 15(d)

Sponsored Research and Clinical Trial Agreements (Tables)

v3.8.0.1
Sponsored Research and Clinical Trial Agreements (Tables)
 3 Months Ended
Mar. 31, 2018
Research and Development [Abstract]  
Schedule of Expense Related to Clinical Research Arrangements
The table below provides a summary of Helocyte’s expense related to its clinical research arrangements, for the three months ended March 31, 2018 and 2017, by agreement as recorded in the Condensed Consolidated Statements of Operations:
 
($ in thousands)
 
For the three months ended March 31
 
 
 
2018
 
2017
 
COH Triplex clinical research and support
 
$
–
 
$
500
 
COH PepVax clinical research and support
 
 
–
 
 
235
 
Total licenses acquired expense
 
$
–
 
$
735
 
Schedule of Expense Related to Sponsered Research Arrangements
The table below provides a summary of Mustang’s expense related to its sponsored research agreements, for the three months ended March 31, 2018 and 2017, by license as recorded in the Condensed Consolidated Statements of Operations:
 
($ in thousands)
 
For the three months ended March 31
 
 
 
2018
 
2017
 
COH CAR T
 
$
500
 
$
500
 
COH - CD123
 
 
150
 
 
20
 
COH - IL13Ra2
 
 
360
 
 
9
 
City of Hope - Manufacturing
 
 
114
 
 
–
 
Fred Hutch - CD20
 
 
266
 
 
 
 
Total
 
$
1,390
 
$
529